Brain-to-Liver Pathway Shields Against Liver Inflammation
Researchers at McMaster University have identified that the hormone GDF15 protects the liver from inflammation through a brain-to-liver signaling pathway. This discovery suggests that GDF15 could be a target for new treatments for metabolic dysfunction-associated steatohepatitis (MASH).
Researchers at McMaster University have discovered that a naturally occurring hormone best known for suppressing appetite and promoting weight loss also helps protect the liver from inflammation through a previously unknown signalling pathway, opening new possibilities for treating advanced fatty liver disease.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in